¶ 1 Leave a comment on paragraph 1 0 [et_pb_section admin_label=”Seksjon” fullwidth=”on” specialty=”off”][et_pb_fullwidth_post_title admin_label=”Fullbreddes innleggstittel” title=”on” meta=”off” author=”on” date=”on” categories=”on” comments=”on” featured_image=”on” featured_placement=”background” parallax_effect=”off” parallax_method=”on” text_orientation=”right” text_color=”light” text_background=”on” text_bg_color=”rgba(21,150,137,0.9)” module_bg_color=”rgba(255,255,255,0)” title_font=”|on|||” title_font_size=”35px” title_all_caps=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid” module_id=”header-image-and-text”]
¶ 2 Leave a comment on paragraph 2 0
¶ 3 Leave a comment on paragraph 3 0 [/et_pb_fullwidth_post_title][/et_pb_section][et_pb_section admin_label=”Seksjon” fullwidth=”off” specialty=”off”][et_pb_row admin_label=”Rad”][et_pb_column type=”2_3″][et_pb_text admin_label=”Tekst” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]
The Scientists Behind the Project
Multi-disiplinary Collaborations
¶ 4 Leave a comment on paragraph 4 0
¶ 5 Leave a comment on paragraph 5 0 NCGC focuses on multiple cancer types and the research groups involved have great competence and extensive cancer research experience.
¶ 6 Leave a comment on paragraph 6 0 [/et_pb_text][/et_pb_column][et_pb_column type=”1_3″][/et_pb_column][/et_pb_row][et_pb_row admin_label=”Rad”][et_pb_column type=”1_3″][et_pb_blurb admin_label=”Bjørn Tore Gjertsen” title=”Bjørn Tore Gjertsen” url=”http://www.uib.no/en/ccbio/73500/signalling-targeted-therapy” url_new_window=”on” use_icon=”off” icon_color=”#7EBEC5″ use_circle=”off” circle_color=”#7EBEC5″ use_circle_border=”off” circle_border_color=”#7EBEC5″ image=”http://kreftgenomikk.no/files/2014/06/Bjørn-Tore-Gjertsen2.jpg” icon_placement=”top” animation=”top” background_layout=”light” text_orientation=”left” use_icon_font_size=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]
¶ 7 Leave a comment on paragraph 7 0 Professor Bjørn Tore Gjertsen is the leader of the Clinical Trial Unit at Haukeland Univeristy Hospital, where he also runs a research group focused on leukaemia research.
¶ 8 Leave a comment on paragraph 8 0 [/et_pb_blurb][/et_pb_column][et_pb_column type=”1_3″][et_pb_blurb admin_label=”Harald Holte and Erlend Smeland” title=”Harald Holte and Erlend Smeland” url=”http://ous-research.no/lymphoma/” url_new_window=”off” use_icon=”off” icon_color=”#7EBEC5″ use_circle=”off” circle_color=”#7EBEC5″ use_circle_border=”off” circle_border_color=”#7EBEC5″ image=”http://kreftgenomikk.no/files/2014/04/Screen-Shot-2014-06-09-at-16.56.25-1.png” icon_placement=”top” animation=”top” background_layout=”light” text_orientation=”left” use_icon_font_size=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]
¶ 9 Leave a comment on paragraph 9 0 The Lymphoma group at OUS – The Norwegian Radium Hospital, led by Harald Holte, is multi-disciplinary, with clinicians and researchers working alongside each other. Postdoctoral fellow Jillian Wise is employed on the NCGC project.
¶ 10 Leave a comment on paragraph 10 0 [/et_pb_blurb][/et_pb_column][et_pb_column type=”1_3″][et_pb_blurb admin_label=”Eivind Hovig” title=”Eivind Hovig” url=”https://www.ous-research.no/hovig/” url_new_window=”off” use_icon=”off” icon_color=”#7EBEC5″ use_circle=”off” circle_color=”#7EBEC5″ use_circle_border=”off” circle_border_color=”#7EBEC5″ image=”http://kreftgenomikk.no/files/2014/04/Eivind-portrett-4.jpg” icon_placement=”top” animation=”top” background_layout=”light” text_orientation=”left” use_icon_font_size=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]
¶ 11 Leave a comment on paragraph 11 0 Professor Eivind Hovig is the leader of the NCGC Bioinformatics, and is head of a research group focused on melanoma research in the Department of Tumour Biology at the Norwegian Radium Hospital. Postdoc Sigve Nakken, PhD-student Daniel Vodák and Programmer Ghislain Fournous are employed in the NCGC Bioinformatics group.
¶ 12 Leave a comment on paragraph 12 0 [/et_pb_blurb][/et_pb_column][/et_pb_row][et_pb_row admin_label=”Rad”][et_pb_column type=”1_3″][et_pb_blurb admin_label=”Ivar Sønbø Kristiansen” title=”Ivar Sønbø Kristiansen” url=”http://www.med.uio.no/helsam/english/people/aca/ivarsk/index.html” url_new_window=”on” use_icon=”off” icon_color=”#7EBEC5″ use_circle=”off” circle_color=”#7EBEC5″ use_circle_border=”off” circle_border_color=”#7EBEC5″ image=”http://kreftgenomikk.no/files/2014/04/Sønbø-Kristiansen.jpg” icon_placement=”top” animation=”top” background_layout=”light” text_orientation=”left” use_icon_font_size=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]
¶ 13 Leave a comment on paragraph 13 0 Professor Ivar Sønbø Kristiansen is the leader of the NCGC Health and Economy project, focused on calculating the cost and benefit of introducing genome-based diagnostics into the health service and basing the choice of treatment on the outcome of these results. He is affiliated with the Department of Leadership and Economy of Health at the University of Oslo. PhD student Anita Iyer is employed on the NCGC project.
¶ 14 Leave a comment on paragraph 14 0 [/et_pb_blurb][/et_pb_column][et_pb_column type=”1_3″][et_pb_blurb admin_label=”Ragnhild A. Lothe” title=”Ragnhild A. Lothe” url=”http://www.ous-research.no/lothe/” url_new_window=”off” use_icon=”off” icon_color=”#7EBEC5″ use_circle=”off” circle_color=”#7EBEC5″ use_circle_border=”off” circle_border_color=”#7EBEC5″ image=”http://kreftgenomikk.no/files/2014/06/Lothe.jpg” icon_placement=”top” animation=”top” background_layout=”light” text_orientation=”left” use_icon_font_size=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]
¶ 15 Leave a comment on paragraph 15 0 Professor dr.philos. Ragnhild A. Lothe, is the leader of the molecular cancer genetics group in the department of Genetics at the institute of Cancer Research at the Norwegian Radium Hospital. Professor Lothe´s research group is mainly focused on colorectal and testicular cancer research. Senior scientist Torstein Tengs is employed on the NCGC project.
¶ 16 Leave a comment on paragraph 16 0 [/et_pb_blurb][/et_pb_column][et_pb_column type=”1_3″][et_pb_blurb admin_label=”Per Eystein Lønning” title=”Per Eystein Lønning” url=”https://helse-bergen.no/fag-og-forsking/forsking/mohn-kreftforskingslaboratorium” url_new_window=”on” use_icon=”off” icon_color=”#7EBEC5″ use_circle=”off” circle_color=”#7EBEC5″ use_circle_border=”off” circle_border_color=”#7EBEC5″ image=”http://kreftgenomikk.no/files/2013/12/Per-Eystein-Lønning_Fotor.jpg” icon_placement=”top” animation=”top” background_layout=”light” text_orientation=”left” use_icon_font_size=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]
¶ 17 Leave a comment on paragraph 17 0 Professor Per Eystein Lønning is oncologist and the leader of a research group located at Haukeland University Hospital and University of Bergen. Rakel Blaalid is employed as a postdoctoral fellow financed by the NCGC.
¶ 18 Leave a comment on paragraph 18 0 [/et_pb_blurb][/et_pb_column][/et_pb_row][et_pb_row admin_label=”Rad”][et_pb_column type=”1_3″][et_pb_blurb admin_label=”Leonardo A. Meza-Zepeda” title=”Leonardo A. Meza-Zepeda” url=”http://ous-research.no/meza-zepeda” url_new_window=”on” use_icon=”off” icon_color=”#7EBEC5″ use_circle=”off” circle_color=”#7EBEC5″ use_circle_border=”off” circle_border_color=”#7EBEC5″ image=”http://kreftgenomikk.no/files/2013/07/Leonardo-med-stol.jpg” icon_placement=”top” animation=”top” background_layout=”light” text_orientation=”left” use_icon_font_size=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]
¶ 19 Leave a comment on paragraph 19 0 Dr Leonardo A. Meza-Zepeda is the leader of translational cancer genomics group in the department of Tumor Biology at the Institute of Cancer Research, Norwegian Radium Hospital. His group is focused on sarcoma and lung cancer research. He is also head of the Core Facility of Genomics, performing the majority of the sequencing analyses for the NCGC project. Postdoctoral Fellow Chandu Cilamakuri and Senior Engineer Jinchang Sun are funded by the NCGC project.
¶ 20 Leave a comment on paragraph 20 0 [/et_pb_blurb][/et_pb_column][et_pb_column type=”1_3″][et_pb_blurb admin_label=”Ola Myklebost” title=”Ola Myklebost” url=”http://myklebost.uib.no/” url_new_window=”off” use_icon=”off” icon_color=”#7EBEC5″ use_circle=”off” circle_color=”#7EBEC5″ use_circle_border=”off” circle_border_color=”#7EBEC5″ image=”http://kreftgenomikk.no/files/2013/07/Ola-blid1.jpg” icon_placement=”top” animation=”top” background_layout=”light” text_orientation=”left” use_icon_font_size=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]
¶ 21 Leave a comment on paragraph 21 0 Professor Ola Myklebost is the Head of the NCGC. He is also the leader of a research group based at OUS – Norwegian Radium Hospital, specialised in sarcoma, tumors of the bone and connective tissues. Postdoctoral Fellow Susanne Lorenz and PhD student Robert Hanes are employed on the NCGC project. Postdoctoral Fellows Else Munthe and Eva Stratford are working on related projects, funded by the Norwegian Cancer Society and Helse Sør-Øst, respectively.
¶ 22 Leave a comment on paragraph 22 0 [/et_pb_blurb][/et_pb_column][et_pb_column type=”1_3″][et_pb_blurb admin_label=”Bioteknologirådet” title=”Bioteknologirådet” url=”http://bioteknologiradet.no/” url_new_window=”on” use_icon=”off” icon_color=”#7EBEC5″ use_circle=”off” circle_color=”#7EBEC5″ use_circle_border=”off” circle_border_color=”#7EBEC5″ image=”http://kreftgenomikk.no/files/2014/04/SigridThoresen2.jpg” icon_placement=”top” animation=”top” background_layout=”light” text_orientation=”left” use_icon_font_size=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]
¶ 23 Leave a comment on paragraph 23 0 Professor Sissel Rogne is the Director of the Norwegian Biotechnology Advisory Board. She is also a Professor in Public Health in Bergen.
¶ 24 Leave a comment on paragraph 24 0 [/et_pb_blurb][/et_pb_column][/et_pb_row][et_pb_row admin_label=”Rad”][et_pb_column type=”1_3″][et_pb_blurb admin_label=”Ole Morten Seternes” title=”Ole Morten Seternes” url=”http://en.uit.no/ansatte/organisasjon/ansatte/person?p_document_id=43746&p_dimension_id=88118″ url_new_window=”on” use_icon=”off” icon_color=”#7EBEC5″ use_circle=”off” circle_color=”#7EBEC5″ use_circle_border=”off” circle_border_color=”#7EBEC5″ image=”http://kreftgenomikk.no/files/2014/04/Bilde-OMSeternes.jpg” icon_placement=”top” animation=”top” background_layout=”light” text_orientation=”left” use_icon_font_size=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]
¶ 25 Leave a comment on paragraph 25 0 Professor Ole Morten Seternes is based at the Institute of Pharmacy at the University of Tromsø. He is in charge of the NCGCs work-package focused on pre-clinical validation of novel treatments. More specifically, the work involves using in vitro and in vivo models to determine whether specific mutations are suitable targets for precision therapy. Postdoctoral Fellow Espen Åberg is employed on the NCGC project.
¶ 26 Leave a comment on paragraph 26 0 [/et_pb_blurb][/et_pb_column][et_pb_column type=”1_3″][et_pb_blurb admin_label=”Jan Helge Solbakk” title=”Jan Helge Solbakk” url=”http://www.med.uio.no/helsam/english/about/organization/departments/medical-ethics/index.html” url_new_window=”on” use_icon=”off” icon_color=”#7EBEC5″ use_circle=”off” circle_color=”#7EBEC5″ use_circle_border=”off” circle_border_color=”#7EBEC5″ image=”http://kreftgenomikk.no/files/2014/06/solbakk.jpg” icon_placement=”top” animation=”top” background_layout=”light” text_orientation=”left” use_icon_font_size=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]
¶ 27 Leave a comment on paragraph 27 0 Professor Solbakk is in charge of the Ethical aspects of the NCGC project. He is based at the University of Oslo, Centre for Medical Ethics. PhD student Isabelle Budin Ljøsne is funded by the NCGC project.
¶ 28 Leave a comment on paragraph 28 0 [/et_pb_blurb][/et_pb_column][et_pb_column type=”1_3″][et_pb_blurb admin_label=”Giske Ursin” title=”Giske Ursin” url=”http://kreftregisteret.no/” url_new_window=”on” use_icon=”off” icon_color=”#7EBEC5″ use_circle=”off” circle_color=”#7EBEC5″ use_circle_border=”off” circle_border_color=”#7EBEC5″ image=”http://kreftgenomikk.no/files/2014/04/Giske.png” icon_placement=”top” animation=”top” background_layout=”light” text_orientation=”left” use_icon_font_size=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid” custom_css_blurb_image=”min-width: 364px !important;”]
¶ 29 Leave a comment on paragraph 29 0 Professor Giske Ursin is the Director of the Cancer Registry.
¶ 30 Leave a comment on paragraph 30 0 [/et_pb_blurb][/et_pb_column][/et_pb_row][et_pb_row admin_label=”Rad”][et_pb_column type=”1_3″][et_pb_blurb admin_label=”Anders Waage og Anders Sundan” title=”Anders Waage og Anders Sundan” url=”http://www.ntnu.edu/myeloma” url_new_window=”on” use_icon=”off” icon_color=”#7EBEC5″ use_circle=”off” circle_color=”#7EBEC5″ use_circle_border=”off” circle_border_color=”#7EBEC5″ image=”http://kreftgenomikk.no/files/2014/03/Sundan-og-Waage.jpg” icon_placement=”top” animation=”top” background_layout=”light” text_orientation=”left” use_icon_font_size=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid” custom_css_blurb_image=”{||height: 164px;||}”]
¶ 31 Leave a comment on paragraph 31 0 Professors Anders Waage and Anders Sundan are leaders of a “KG Jebsen Centre” for myeloma research based at St Olavs University Hospital and NTNU. Senior Scientist Eivind Coward and a Postdoctoral Fellow are funded by the NCGC project.
¶ 32 Leave a comment on paragraph 32 0 [/et_pb_blurb][/et_pb_column][et_pb_column type=”1_3″][/et_pb_column][et_pb_column type=”1_3″][/et_pb_column][/et_pb_row][/et_pb_section]